FAQ

SCH94.03 monoclonal antibody

Known as: SCH94.03, monoclonal antibody SCH94.03, monoclonal autoantibody SCH94.03 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-1996
0119941996

Related topics

Related topics

1 relation

Broader (1)

Monoclonal Antibodies

Related mentions per year

Related mentions per year

1971-2018
197019801990200020102020
SCH94.03 monoclonal antibody
Monoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody.
We postulated that humoral autoimmunity can play a beneficial role in CNS demyelinating diseases such as multiple sclerosis. We… (More)
Is this relevant?
1996
1996
A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination.
We have used an established experimental model of multiple sclerosis to investigate the potential beneficial relationship between… (More)
Is this relevant?
1995
1995
A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes.
Antibodies directed against self-Ags are frequently considered detrimental, and have been shown to play a pathogenic role in… (More)
Is this relevant?
1994
1994
Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis.
Susceptible strains of mice infected intracerebrally with Theiler's murine encephalomyelitis virus develop a chronic, progressive… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?